RESTON, Va.--(BUSINESS WIRE)--VeriSign, Inc. (NASDAQ: VRSN), a global provider of critical internet infrastructure and domain name registry services, today announced that, according to the latestDomain Name Industry Brief Quarterly Report&n
Next Generation Layer-2 Protocol Delivers the Best Access to Bitcoin Security and Deeper Interoperability Between the Two Networks That Drive the Blockchain EcosystemKey FactsLaunching at the Bitcoin 2024 conference in Nashville, the larges
H1 2024 Key figures2 Revenue of EUR 3,021.7 million in the first half of 2024, up 4.0% year on year and up 9.2% organically (including 10.4% in the second quarter) Adjusted operating profit of EUR 451.9 m
PARIS--(BUSINESS WIRE)--Bureau Veritas, a global leader in the Testing, Inspection and Certification (TIC) industry, announces today it has signed an agreement to acquire Security Innovation Inc., a US-based specialized software security fi
PARIS--(BUSINESS WIRE)--Bureau Veritas, a global leader in the Testing, Inspection and Certification (TIC) industry, announces the appointment of Maria Lorente Fraguas as Executive Vice President and Chief People Officer, effective October
Ad hoc announcement pursuant to Art. 53 LRZUG, Switzerland--(BUSINESS WIRE)--Galderma Group AG, the pure-play dermatology category leader, today announced its financial results for the first half of 2024.Record net sales of 2.2 billion US
Detailed results from the phase III ARCADIA 1 and 2 trials evaluating the safety and efficacy of nemolizumab in atopic dermatitis were published for the first time in The Lancet1Data from this phase III program demonstrate the potential of
纽约--(美国商业资讯)-- The Este Lauder Companies Inc. (NYSE: EL)(以下称为 ELC 或 公司)今天宣布,Akhil Shrivastava已被任命为执行副总裁兼首席财务官,接替于2024年7月11日宣布计划退休的Tracey T. Travis。Akhil与Tracey 的汇报结构保持一致,将向执
俄亥俄州梅森--(美国商业资讯)--心房颤动(Afib)、左心耳(LAA)管理和术后疼痛管理外科治疗和疗法领域的领先创新企业AtriCure, Inc. (Nasdaq: ATRC)今天宣布,其已获得中国国家药品监督管理局(NMPA)的监管批准,可以上市销售其AtriClip左心耳(LAA)封堵系统的多
续约加强了KBI建立长期合作伙伴关系的承诺,以成功应对复杂的临床开发和商业化挑战北卡罗来纳州达勒姆--(美国商业资讯)-- JSR Life Sciences旗下公司、全球cGMP合同开发和制造组织(CDMO) KBI Biopharma, Inc. (KBI)今天宣布,其已续签并扩大了与一家全球领先